No Evidence That Androgen Regulation of Pulmonary TMPRSS2 Explains Sex-Discordant COVID-19 Outcomes
Authors: Mehdi Baratchian1, Jeffrey McManus1, Mike Berk1, Fumihiko Nakamura1, Serpil Erzurum2,3, Sanjay Mukhopadhyay4, Judy Drazba5, John Peterson5, Ben Gaston6, Nima Sharifi1,7,8
1. Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic
2. Department of Pathobiology, Lerner Research Institute, Cleveland Clinic
3. Respiratory Institute, Cleveland Clinic
4. Pathology and Laboratory Medicine Institute, Cleveland Clinic
5. Imaging Core, Lerner Research Institute, Cleveland Clinic
6. Herman Wells Center for Pediatric Research, Indiana University School of Medicine
7. Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic
8. Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic
Citation: Baratchian, Mehdi, Jeffrey McManus, Mike Berk, Fumihiko Nakamura, Serpil Erzurum, Sanjay Mukhopadhyay, Judy Drazba, John Peterson, Ben Gaston, and Nima Sharifi. “No Evidence That Androgen Regulation of Pulmonary TMPRSS2 Explains Sex-Discordant COVID-19 Outcomes.” BioRxiv, April 21, 2020, 2020.04.21.051201. https://doi.org/10.1101/2020.04.21.051201.